Sarms Research Compounds

18 compounds. All third-party HPLC tested. Certificate of Analysis on every order. For Research Use Only (RUO).

Selective Androgen Receptor Modulators (SARMs)

Selective Androgen Receptor Modulators (SARMs) are a class of research compounds designed to interact with androgen receptors in a tissue-selective manner. Unlike traditional anabolic steroids, which bind androgen receptors systemically and produce broad hormonal effects, SARMs are engineered to preferentially target muscle and bone tissue — making them a subject of significant interest in research areas including muscle wasting diseases, osteoporosis, hormone replacement therapy, and metabolic syndrome.

In preclinical studies, SARMs such as RAD-140 (Testolone), LGD-4033 (Ligandrol), and Ostarine (MK-2866) have demonstrated measurable anabolic activity in muscle and bone tissue with reduced androgenic effects on the prostate and other sensitive tissues. MK-677 (Ibutamoren), while not a SARM in the classic receptor-binding sense, is commonly studied alongside SARMs as a growth hormone secretagogue with strong research literature supporting its effects on IGF-1 elevation and nitrogen retention.

Rainbow Peptide's SARMs catalog includes 9 third-party tested compounds — RAD-140, LGD-4033, Ostarine, MK-677, Andarine (S4), Cardarine (GW501516), SR9009 (Stenabolic), YK-11, and Enclomiphene. All are supplied at >98% HPLC purity with COA documentation.

For Research Use Only (RUO). SARMs are not approved for human use and are sold strictly for in vitro and laboratory research purposes.